Dual-action approach targeting inflammation shows potential as type 1 diabetes treatment
A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the progression of type 1 diabetes by targeting an inflammation-related protein known to drive the disease.
May 7, 2025
0
0